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Why Study Heart Failure?
 Heart failure = cardiac output that is insufficient 
to meet the demands of the body.
 Affects 6.5 million US adults (~3% of pop.)
 1 in 8 deaths has heart failure mentioned on 
death certificate.1
 Digoxin causes an increase in cardiac  
contraction strength, but has a narrow 
therapeutic window.2
1. AHA 2017 Statistical Update, Circulation, 135:e378-e384.
2. Bers, DM.  EC Coupling and Cardiac Contractile Force, 2001.
Digoxin
Central Question


























Approach for Screening Mutants:




















HEK cells co-transfected with 
CFP-NKA and PLM-
Cell line courtesy of Dr. Julie Bossuyt (UC Davis)

FRET Eff. (%) = FRETmax*[Protein]n / (KDn + [Protein]n) 
Measuring Binding Affinity with FRET


















































































Video courtesy of Dan Blackwell




































































































































































































































































































































































Intracellular [Ca2+] Myocyte Contraction
+ adrenaline
Conclusions
 L30A PLM caused increased binding to NKA.
 L30A PLM mimics the effect of digoxin on isolated 
cardiomyocytes.
 Adrenaline relieved this effect.
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Academic Research 
Collaborations Program
In addition to providing direct-to-
consumer genetic testing through the 
23andMe® Service, 23andMe 
endeavors to advance biomedical 
science through genetic research.
Some of those discoveries have and 
will come from our own scientists, but 
others will come from collaborations 
with academic researchers external 
to 23andMe through the 23andMe 
Academic Research Collaboration 
Program.
